Clinical trials recruiting for Advanced Malignant Solid Neoplasm
13
Recruiting trials
46
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 4 |
| Texas | 4 |
| Florida | 3 |
| Illinois | 3 |
| Oklahoma | 3 |
| Oregon | 3 |
| Tennessee | 3 |
| Colorado | 2 |
| Connecticut | 2 |
| Maryland | 2 |
| Massachusetts | 2 |
| Missouri | 2 |
Top cities
Houston, Texas 4Nashville, Tennessee 3Oklahoma City, Oklahoma 3Portland, Oregon 3Bethesda, Maryland 2Boston, Massachusetts 2Buffalo, New York 2Chicago, Illinois 2City of Saint Peters, Missouri 2Creve Coeur, Missouri 2
Self-screener
Recruiting trials
- A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
- IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
- Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
- Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
- Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies
- TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
- Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
- Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
- Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer
Related conditions
Trials recruiting for Advanced Malignant Solid Neoplasm often also study these conditions. Each links to its own recruiting-trial list.
Metastatic Malignant Solid Neoplasm 21Lung cancer 2180Pancreatic cancer 870Colorectal cancer 1359Advanced Biliary Tract Carcinoma 4Unresectable Malignant Solid Neoplasm 8Stage IV Pancreatic Cancer AJCC v8 19Stage IV Colorectal Cancer AJCC v8 21Stage III Pancreatic Cancer AJCC v8 14Stage III Colorectal Cancer AJCC v8 10
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Advanced Malignant Solid Neoplasm trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.